Chargement en cours...
Novel Molecular Targets for the Treatment of Gastroenteropancreatic Endocrine Tumors: Answers and Unsolved Problems
As more knowledge on molecular alterations favoring carcinogenesis and spreading of gastroenteropancreatic endocrine tumors has become available, a number of targeted agents interfering with key growth and angiogenic pathways have been explored in preclinical and clinical studies. The mTOR inhibitor...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI
2012
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3565249/ https://ncbi.nlm.nih.gov/pubmed/23344019 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms14010030 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|